Tegretol is a first-line treatment for partial and generalized seizures and is also used for bipolar disorder and trigeminal neuralgia. It works by stabilizing sodium channels to reduce neuronal excitability. Common side effects include ataxia, dizziness, nausea and vomiting, and dry mouth. Rare side effects include myocardial infarction and Stevens-Johnson syndrome. Patients should be advised to avoid grapefruit, alcohol, and sudden discontinuation of the drug which could cause status epilepticus. Tegretol is associated with autoinduction where it stimulates hepatic enzymes over time, leading to lower drug concentrations.